Cellyan Biotechnology Co Ltd

HKPD

Company Profile

  • Business description

    Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.

  • Contact

    13 Ko Fai Road
    Room B1, 5th Floor, Well Town Industrial Building
    Yau Tong
    Kowloon
    Hong Kong
    HKG

    T: +852 26189289

    http://www.9zt.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Distribution

    Fiscal Year End

    31 March 2027

    Employees

    27

Stocks News & Analysis

stocks

Avoid this overvalued ASX healthcare share

Expensive healthcare share limited by its core addressable market.
stocks

AI driving growth for ASX tech share

ASX tech share raises funds to facilitate customer AI spend.
stocks

OpenAI is going public as the worst value among its peers

Investors are paying a steep price relative to the underlying business quality, PitchBook research says.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,824.8067.500.77%
CAC 408,203.434.140.05%
DAX 4024,433.06183.16-0.74%
Dow JONES (US)50,872.1186.100.17%
FTSE 10010,227.33145.87-1.41%
HKSE24,565.9091.16-0.37%
NASDAQ25,678.82250.84-0.97%
Nikkei 22565,416.631,392.032.17%
NZX 50 Index13,163.1940.89-0.31%
S&P 5007,386.6519.08-0.26%
S&P/ASX 2008,604.2070.700.83%
SSE Composite Index4,010.0350.691.28%

Market Movers